Information Collection Request

Community Context Matters Study

ICR 201605-0920-006 · OMB 0920-1038 · Historical Active

Forms and Documents
DocumentTypeStatusAvailability
Key Stakeholder Interview Form Modified Repair queued
Neighborhood Interview Form Modified Available
SS_Part B. doc.doc Supporting Statement B Uploaded 2016-05-12 Repair queued
CHANGE_REQUEST_201408-0920-1038_May2016.docx Justification for No Material/Nonsubstantive Change Uploaded 2016-05-12 Available
SS_PartA.docx Supporting Statement A Uploaded 2016-05-12 Available
Philly_IRB_ContxtMatters_2014.pdf Supplementary Document Uploaded 2014-08-13 Available
6531 New Site Restricted Approval.docx Supplementary Document Uploaded 2014-08-13 Available
Full Board Approval -- #14.03.01 (Michaels) Initial Submission.pdf Supplementary Document Uploaded 2014-08-13 Available
Att 2 60Day FRN.pdf Supplementary Document Uploaded 2014-08-11 Available
Att 1_Auth Legislation.docx Supplementary Document Uploaded 2014-08-11 Available
IC Document Collections
IC IDCollectionTypeStatusForm
212650 Key Stakeholder Interview Form Modified
212624 Neighborhood Interview Form Modified
212623 Key Stakeholder Recruitment and Consent Instruction Unchanged
212621 Neighborhood Interview Recruitment and Consent Instruction Modified
ICR Details
0920-1038 201605-0920-006
Historical Active 201408-0920-005
HHS/CDC 16AJC
Community Context Matters Study
No material or nonsubstantive change to a currently approved collection   No
Regular
Approved without change 05/26/2016
Retrieve Notice of Action (NOA) 05/12/2016
  Inventory as of this Action Requested Previously Approved
12/31/2017 12/31/2017 12/31/2017
600 0 500
110 0 91
0 0 0

The daily use of specific antiretroviral medications by persons without HIV, but at high risk of exposure to HIV, has been shown to be a safe and effective HIV prevention method. The FDA approved the use of Truvada® for preexposure prophylaxis (PrEP) and CDC has issued clinical practice guidelines for its use. CDC requests approval to assess the utility of new measures developed or adapted to collect information related to this new intervention and to evaluate community contextual factors that may impact the acceptability and successful introduction of a new HIV prevention method. The project will be conducted in communities where PrEP has become available through a local community health center - a community-based survey in public venues in the catchment areas of the PrEP clinics, and key stakeholder surveys community HIV leaders. The surveys will collect demographic data, knowledge of PrEP, misinformation about PrEP, and attitudes about it. This request is to add another clinic and change 2 of the survey sites.

US Code: 42 USC 301 Name of Law: PHSA
  
None

Not associated with rulemaking

  79 FR 24439 04/30/2014
79 FR 47465 08/13/2014
No

  Total Approved Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 600 500 0 100 0 0
Annual Time Burden (Hours) 110 91 0 19 0 0
Annual Cost Burden (Dollars) 0 0 0 0 0 0
Yes
Miscellaneous Actions
No
Request to add respondents due to adding a clinic to increase respondent diversity, changing some of the study sites, and a minor wording change in one question. Burden increase due to increase in respondents.

$234,700
Yes Part B of Supporting Statement
No
No
No
No
Uncollected
Shari Steinberg 404 639-4942 [email protected]

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
05/12/2016